Works matching IS 15228517 AND DT 2023 AND VI 25 AND IP 5
Results: 22
Corrigendum to: Association of circulating markers with cognitive decline after radiation therapy for brain metastasis.
- Published in:
- 2023
- Publication type:
- Correction Notice
Society News.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 5, p. 1013, doi. 10.1093/neuonc/noad061
- Publication type:
- Article
Corrigendum to: NCOG-45. Differential and dose-dependent effects of cranial irradiation on brain structures and neuropsychological outcomes in children with posterior fossa brain tumors treated with different modalities.
- Published in:
- 2023
- Publication type:
- Correction Notice
While paradigms shift in von Hippel-Lindau management, questions remain in optimal multidisciplinary neuro-oncology care.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 5, p. 839, doi. 10.1093/neuonc/noad049
- By:
- Publication type:
- Article
Corrigendum to: IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification.
- Published in:
- 2023
- Publication type:
- Correction Notice
DUB-ling down on the epigenetic regulation of cancer stem cells in glioblastoma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 5, p. 854, doi. 10.1093/neuonc/noad040
- By:
- Publication type:
- Article
Targeted anticonvulsive treatment of IDH-wildtype glioblastoma based on DNA methylation subclasses.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 5, p. 1006, doi. 10.1093/neuonc/noad014
- By:
- Publication type:
- Article
EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 5, p. 813, doi. 10.1093/neuonc/noad008
- By:
- Publication type:
- Article
Rethinking classification and categorization of resection extent and its impact on patient survival in glioblastoma: Was Walter Dandy ahead of his time?
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 5, p. 955, doi. 10.1093/neuonc/noad013
- By:
- Publication type:
- Article
BI-907828, a novel potent MDM2 inhibitor, inhibits glioblastoma brain tumor stem cells in vitro and prolongs survival in orthotopic xenograft mouse models.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 5, p. 913, doi. 10.1093/neuonc/noac271
- By:
- Publication type:
- Article
Impact of maximal extent of resection on postoperative deficits, patient functioning, and survival within clinically important glioblastoma subgroups.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 5, p. 958, doi. 10.1093/neuonc/noac255
- By:
- Publication type:
- Article
RAGE ablation attenuates glioma progression and enhances tumor immune responses by suppressing galectin-3 expression.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 5, p. 886, doi. 10.1093/neuonc/noac250
- By:
- Publication type:
- Article
Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 5, p. 940, doi. 10.1093/neuonc/noac193
- By:
- Publication type:
- Article
Incidence proportion and prognosis of leptomeningeal disease among patients with breast vs. non-breast primaries.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 5, p. 973, doi. 10.1093/neuonc/noac249
- By:
- Publication type:
- Article
Elucidating the neurological mechanism of the FLASH effect in juvenile mice exposed to hypofractionated radiotherapy.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 5, p. 927, doi. 10.1093/neuonc/noac248
- By:
- Publication type:
- Article
ARL13B promotes angiogenesis and glioma growth by activating VEGFA-VEGFR2 signaling.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 5, p. 871, doi. 10.1093/neuonc/noac245
- By:
- Publication type:
- Article
Epigenetic upregulation of Schlafen11 renders WNT- and SHH-activated medulloblastomas sensitive to cisplatin.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 5, p. 899, doi. 10.1093/neuonc/noac243
- By:
- Publication type:
- Article
A novel compound EPIC-0412 reverses temozolomide resistance via inhibiting DNA repair/MGMT in glioblastoma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 5, p. 857, doi. 10.1093/neuonc/noac242
- By:
- Publication type:
- Article
Neurological applications of belzutifan in von Hippel-Lindau disease.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 5, p. 827, doi. 10.1093/neuonc/noac234
- By:
- Publication type:
- Article
USP36 promotes tumorigenesis and drug sensitivity of glioblastoma by deubiquitinating and stabilizing ALKBH5.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 5, p. 841, doi. 10.1093/neuonc/noac238
- By:
- Publication type:
- Article
Disease burden, risk factors, and trends of primary central nervous system (CNS) cancer: A global study of registries data.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 5, p. 995, doi. 10.1093/neuonc/noac213
- By:
- Publication type:
- Article
Prediction of response to lomustine-based chemotherapy in glioma patients at recurrence using MRI and FET PET.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 5, p. 984, doi. 10.1093/neuonc/noac229
- By:
- Publication type:
- Article